Mapp Biopharmaceutical gets up to $46.5 million for new viral disease drug

June 10, 2019 sandiegobiotech News Comments Off on Mapp Biopharmaceutical gets up to $46.5 million for new viral disease drug
Mapp Biopharmaceutical gets up to $46.5 million for new viral disease drug
/

Treatment for deadly hemorrhagic fever viruses to be taken into human safety testing